Investors Sell Shares of Walgreens Boots Alliance (WBA) on Strength (WBA)

Traders sold shares of Walgreens Boots Alliance (NASDAQ:WBA) on strength during trading hours on Wednesday. $31.81 million flowed into the stock on the tick-up and $77.72 million flowed out of the stock on the tick-down, for a money net flow of $45.91 million out of the stock. Of all equities tracked, Walgreens Boots Alliance had the 0th highest net out-flow for the day. Walgreens Boots Alliance traded up $1.13 for the day and closed at $65.74

Several equities analysts recently commented on the company. BidaskClub downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, May 8th. ValuEngine downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 price objective on the stock in a research note on Saturday, April 7th. Jefferies Group set a $85.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, April 3rd. Finally, Scotiabank dropped their price objective on Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating on the stock in a research note on Monday, April 2nd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Buy” and an average target price of $83.20.

The stock has a market capitalization of $65.19 billion, a PE ratio of 12.60, a price-to-earnings-growth ratio of 1.07 and a beta of 1.15. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.45 and a current ratio of 0.90.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The company had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. During the same period in the previous year, the business earned $1.36 earnings per share. The firm’s quarterly revenue was up 12.1% compared to the same quarter last year. analysts expect that Walgreens Boots Alliance will post 5.92 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Shareholders of record on Friday, May 18th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is 31.37%.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Wednesday, May 2nd. The shares were sold at an average price of $65.56, for a total transaction of $179,372.16. Following the completion of the transaction, the director now owns 13,679 shares of the company’s stock, valued at $896,795.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Chesley Taft & Associates LLC boosted its holdings in Walgreens Boots Alliance by 48.6% during the fourth quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock worth $18,981,000 after buying an additional 85,423 shares in the last quarter. North Star Investment Management Corp. increased its stake in Walgreens Boots Alliance by 4.7% in the 4th quarter. North Star Investment Management Corp. now owns 86,163 shares of the pharmacy operator’s stock valued at $6,257,000 after buying an additional 3,868 shares during the period. Boyd Watterson Asset Management LLC OH increased its stake in Walgreens Boots Alliance by 29.0% in the 4th quarter. Boyd Watterson Asset Management LLC OH now owns 37,579 shares of the pharmacy operator’s stock valued at $2,729,000 after buying an additional 8,437 shares during the period. Sawyer & Company Inc acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at $236,000. Finally, Acropolis Investment Management LLC increased its stake in Walgreens Boots Alliance by 955.8% in the 4th quarter. Acropolis Investment Management LLC now owns 2,439 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 2,208 shares during the period. 61.52% of the stock is owned by institutional investors and hedge funds.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply